维生素D补充对急性创伤性脑损伤患者的影响
回顾性研究纳入345例创伤性脑损伤患者,2016年8月至12月未补充维生素D者为对照组,2017年1月起对入院时维生素D水平低者补充维生素D为补充组。补充组维生素D水平从入院时14.03 ± 8.68 ng/mL升至3个月时37.42 ± 12.57 ng/mL(P < 0.001),认知结局和GOS-E评分从第1周至3个月显著改善。作者认为轻中度创伤性脑损伤伴显著维生素D缺乏者急性期补充维生素D可能改善长期表现和认知结局。
要点
- 创伤性脑损伤患者入院时平均维生素D水平为13.62 ± 9.01 ng/mL。
- 补充组维生素D水平从入院时14.03 ± 8.68 ng/mL升至3个月时37.42 ± 12.57 ng/mL(P < 0.001)。
- 补充维生素D者认知结局(MMSE P = 0.042,CDR P = 0.044)和GOS-E评分(总TBI P = 0.003;轻中度TBI P = 0.002)从第1周至3个月显著改善。
核心结论
- 作者认为,轻中度创伤性脑损伤伴显著维生素D缺乏者在损伤急性期补充维生素D可能改善长期表现和认知结局。
- 作者认为,创伤性脑损伤患者的治疗策略应基于基线维生素D水平个体化制定。
研究设计与样本
- 回顾性研究,纳入345例就诊于单一创伤中心的创伤性脑损伤患者。
- 2016年8月至12月入院时未补充维生素D、仅测量血清维生素D水平者为对照组。
- 2017年1月起对入院时血清维生素D水平低的创伤性脑损伤患者提供维生素D补充为补充组。
- 在创伤性脑损伤后1周和3个月评估扩展格拉斯哥结局量表(GOS-E)、简易精神状态检查(MMSE)和临床痴呆评定量表(CDR)。
主要发现
- 创伤性脑损伤患者入院时平均血清维生素D水平为13.62 ± 9.01 ng/mL。
- 补充组血清维生素D水平从入院时14.03 ± 8.68 ng/mL升至创伤性脑损伤后3个月时37.42 ± 12.57 ng/mL(P < 0.001)。
- 补充维生素D患者MMSE(P = 0.042)和CDR(P = 0.044)从创伤性脑损伤后第1周至3个月显著改善。
- 补充维生素D患者GOS-E评分从创伤性脑损伤后第1周至3个月显著改善(总TBI P = 0.003;轻中度TBI P = 0.002)。
临床怎么用
- 作者认为,轻中度创伤性脑损伤伴显著维生素D缺乏者急性期补充维生素D可能改善长期表现和认知结局。
- 作者认为,创伤性脑损伤患者的治疗策略应基于基线维生素D水平个体化制定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the acute and long-term effects of vitamin D supplementation on the recovery of patients with traumatic brain injury (TBI). METHODS: A retrospective study was conducted involving 345 patients with TBI who visited a single trauma center. Vitamin D serum levels were measured without supplementation at admission, 1 month, and 3 months post-TBI (control group) from August to December 2016. From January 2017, vitamin D supplementation was provided to patients with TBI with low vitamin D serum levels at admission (supplement group). The outcomes were investigated by assessing performance function (Extended Glasgow Outcome Scale) and cognitive function (Mini-Mental Status Examination, and Clinical Dementia Rating) at 1 week and 3 months post-TBI. RESULTS: The mean vitamin D serum level in patients with TBI at admission was 13.62 ± 9.01 ng/mL. The level significantly increased from 14.03 ± 8.68 ng/mL at admission to 37.42 ± 12.57 ng/mL at 3 months post TBI in the supplement group (P < 0.001). The cognitive outcomes (Mini-Mental Status Examination/Clinical Dementia Rating, P = 0.042/P = 0.044) and GOS-E score (total TBI, P = 0.003; mild-to-moderate TBI, P = 0.002) significantly improved from the first week to 3 months post TBI in the patients with vitamin D supplementation. CONCLUSIONS: Administration of vitamin D supplements in mild-to-moderate TBI patients with significant vitamin D deficiency during the acute phase of the injury may improve long-term performance and cognitive outcomes. Therefore, the treatment strategies should be individually planned for the patients with TBI based on their baseline vitamin D level.
引用
- Lee JM, Jeong SW, Kim MY, et al. The Effect of Vitamin D Supplementation in Patients with Acute Traumatic Brain Injury. World Neurosurg. 2019. PMID: 30904798. doi:10.1016/j.wneu.2019.02.244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。